MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.jaci.2010.03.028

Медицинская библиотека · The Journal of allergy and clinical immunology · 2010

Mepolizumab as a steroid-sparing treatment option in patients with Churg-Strauss syndrome.

Kim Sophia, Marigowda Gautham, Oren Eyal, Israel Elliot, Wechsler Michael E

СтатьяПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

BACKGROUND

Treatments for Churg-Strauss syndrome (CSS), a rare eosinophilic vasculitis characterized by asthma, sinusitis, peripheral eosinophilia, pulmonary infiltrates, and tissue infiltration, are limited by toxicity or poor efficacy. Levels of IL-5, a cytokine regulating eosinophils, can be increased in patients with CSS. Mepolizumab, a humanized monoclonal anti-IL-5 antibody, decreases steroid requirements in patients with non-CSS hypereosinophilic syndromes.

OBJECTIVE

The purpose of this study was to assess whether mepolizumab would safely allow corticosteroid tapering in patients with steroid-dependent CSS while decreasing serum markers of disease activity.

METHODS

This open-label pilot study treated 7 patients with 4 monthly doses of mepolizumab to assess whether it safely decreased CSS disease activity and permitted tapering of systemic corticosteroids.

RESULTS

Mepolizumab was safe and well tolerated in patients with CSS. Mepolizumab reduced eosinophil counts and allowed for safe corticosteroid reduction in all 7 subjects. On cessation of mepolizumab, CSS manifestations recurred, necessitating corticosteroid bursts.

CONCLUSION

Mepolizumab is a safe and well-tolerated therapy in patients with CSS, offering clinical benefit by enabling corticosteroid tapering while maintaining clinical stability.

Для цитирования: Kim Sophia, Marigowda Gautham, Oren Eyal, Israel Elliot, Wechsler Michael E. Mepolizumab as a steroid-sparing treatment option in patients with Churg-Strauss syndrome.. The Journal of allergy and clinical immunology. 2010. DOI: 10.1016/j.jaci.2010.03.028.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.